UNSPSC 51172138: Methylchromone or tricromyl

This classification denotes an antispasmotic agent with the molecular formula C10H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KJ0091KAAH, chemically known as 4h-1-benzopyran-4-one, 3-methyl- but generally known as methylchromone, which bears US NIH Compound Identifier 66569. European Medicines Agency schedules Methylchromone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08864MIG.

The term METHYLCHROMONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). METHYLCHROMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Methylchromone or tricromyl bears US NLM identifiers UMLS ID C1881805 and NCI Concept Code C66121. SMILES: O1C2C(C(=O)C(C1)C)CCCC2.

UNSPSC 51172138 Methylchromone or tricromyl is a Commodity code that shows a mismatch between its nominal scope and actual recent state and local procurement activity. The three most recent opportunities tagged to this code involve offender drug testing services, direct-to-manufacturer pharmaceutical procurement strategy, and generic multi-source pharmaceuticals and over-the-counter products — none of which concern methylchromone or tricromyl as chemical compounds. The code appears to be a misclassification artifact in state and local procurement systems rather than an active commodity category for business development purposes.

The Collin County Community Supervision and Corrections Department RFP 2026-327, posted July 9, 2026 with proposals due July 23, 2026, solicits offender specimen collection and drug testing services with an estimated contract value of $600,000 and a two-year term with optional renewals. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs for state pharmacy benefit programs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Activity is geographically dispersed across Texas, Minnesota, and Oregon, with issuing bodies spanning county corrections departments, state health agencies, and cooperative purchasing alliances. The code's recent activity does not reflect a coherent commodity market and warrants verification against the correct UNSPSC classification for pharmaceutical and drug testing procurement.